Annual Scientific Report 2011
Total Page:16
File Type:pdf, Size:1020Kb
Roselló, 149-153 08036 Barcelona www.idibaps.org Your gateway to IDIBAPS. A portal open to medical professionals, scientists and biomedicine enthusiasts where you will find information about the institution and its activities Annual Scientific Report 2011 The mission of IDIBAPS is to combine high-quality clinical research with high-level basic research in order to achieve a more effective transfer of scientific results in the prevention and treatment of the most common health issues in our country. ANNUAL SCIENTIFIC REPORT Hospital Clínic – Fundació Clínic University of Barcelona – Faculty of Medicine CSIC – Institut d’Investigacions Biomèdiques de Barcelona (IIBB) (Spanish National Scientific Research Council – Barcelona Institute of Biomedical Research) Rosselló, 149-153 Generalitat de Catalunya – Departament d’Economia i Coneixement 08036 Barcelona (Catalan Autonomous Government – Ministry for the Economy www.idibaps.org and Knowledge) Published by: IDIBAPS Rosselló, 149-153 – 08036 Barcelona Editorial Board: Dr Ramon Gomis, IDIBAPS Director Dr Joan Rodés, Member of the IDIBAPS Scientific Council Dr Pastora Martínez, IDIBAPS Managing Director Mrs Teresa Peña, Fundació Clínic Research Management Office Mrs Sandra Vidal, Fundació Clínic Technical Office Mrs Gemma Pedrola, IDIBAPS Assistant to the Director Mr Àlex Argemí, IDIBAPS Communication Officer Production and design: BPMO Edigrup C/ Guitard, 43, 1ª planta 08014 Barcelona Tel.: 933 637 840 www.bpmoedigrup.com Legal Deposit: B-47.798-2005 Centres de recerca de Catalunya IDIBAPS is accredited as a Health This centre has been cofinanced by the European Union through Care Research Institute by the the European Regional Development Fund (ERDF) Carlos III Health Institute INDEX Foreword IDIBAPS • INTRODUCTION ................................................................................................................................................................................... 8 • IDIBAPS RESEARCH AND INNOVATION ............................................................................................................................................. 14 • SCIENTIFIC CORE FACILITIES .............................................................................................................................................................. 30 • NETWORKING ..................................................................................................................................................................................... 38 • TRAINING ............................................................................................................................................................................................ 51 • IDIBAPS AND SOCIETY ........................................................................................................................................................................ 55 1 AREA 1 BIOLOGICAL AGGRESSION AND RESPONSE MECHANISM ............................................................................................ 56 2 AREA 2 RESPIRATORY, CARDIOVASCULAR, RENAL AND PATHOBIOLOGY BIOENGINEERING .................................................... 96 3 AREA 3 LIVER, DIGESTIVE SYSTEM AND METABOLISM .............................................................................................................. 140 4 AREA 4 CLINICAL AND EXPERIMENTAL NEUROSCIENCE ............................................................................................................. 196 5 AREA 5 ONCOLOGY AND HAEMATOLOGY .................................................................................................................................... 254 Transversal research groups ..................................................................................................................................... 308 Index • TEAM LEADERS INDEX ....................................................................................................................................................................... 321 6 August Pi i Sunyer (Barcelona 1879 – Mexico 1965), eminent doctor and politician who changed the entire course of biomedicine and politics in this country, after whom this Institute is named. The Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a public research centre dedicated to translational research in the field of biomedicine. It aims to integrate state-of-the-art basic research and quality clinical research in order to acquire and transfer knowledge concerning the main health problems present in our society, with the final purpose of improving their prevention and treatment. Inno- vation and technological progress are therefore essential lines of activity at IDIBAPS. The IDIBAPS task force combines more than 460 researchers, making IDIBAPS probably one of the most powerful translational research centres in Spain. IDIBAPS is located in a melting pot for biomedical research, Barcelona Clinic Campus. The University of Barcelona School of Medicine and Barcelona’s Hospital Clínic are found in the same area. This institutional combination is ideal for creating powerful synergies and ensuring that the IDIBAPS research is efficiently trans- ferred to the patient and included in the training of new health professionals. The Centre’s research activities are divided into five different areas which group over 59 top-level research teams and over 460 investigators. IDIBAPS’ researchers are distributed into the following fields of activity: Biological Aggression and Response Mechanisms (Area 1), Respiratory, Cardiovascular and Renal Pathobiology and Bio- engineering (Area 2), Liver, Digestive System and Metabolism (Area 3), Clinical and Experimental Neuroscience (Area 4), and Oncology and Haematology (Area 5). The data presented in this Annual Scientific Report detail the ever-growing scien- tific output led by IDIBAPS’ investigators, and their capacity for attracting public and private funding. In 2011, they reached a new record, with 906 original articles published in high-impact-factor scientific journals. This is only possible thanks to hard work, enthusiasm and infrastructures such as the recently built Esther Kop- lowitz Research Centre or the soon-to-be-finished CELLEX Research Centre. This enormous potential for capturing resources and their conversion into results ap- plicable to clinical practice constitute the best guarantee for securing the future of the Institute. Scientific breakthroughs are never the result of chance. They are long-term com- mitments that involve not only researchers, but also society as a whole. IDIBAPS is a consortium that undertakes such a commitment in Catalonia: to encourage translational research, innovation and technological progress in the field of biomed- icine through different programmes addressing diseases with a high prevalence, and high morbidity and mortality rates. 7 INTRODUCTION Esther Koplowitz Research Centre (CEK) – Patronage to continue innovating In order to guarantee financial stability and ensure con- Salud Carlos III) and the University of Barcelona (Uni- tinuity, IDIBAPS recognizes that the financing of R&D versitat de Barcelona), as well as the support of other and research institutes should not only come from patrons such as the Esther Koplowitz Foundation, public agencies but also from private funding institu- the Cellex Private Foundation, Sardà Farriol Action for tions. Therefore, fundraising is extremely important Diabetes Research (Acción Sardà Farriol para la Inves- at two levels: at the researcher level to finance their tigación en Diabetes) and Laboratoris Esteve. own research and at the institutional level to be able to finance strategic infrastructures and interventions. The Funded with a capital contribution of €15 million from ability to obtain private funds is also a reflection of the the Esther Koplowitz Foundation to the Clínic Foun- quality and prestige of the institution and its research- dation, the investment in the building exceeds €50 ers. In this aspect, IDIBAPS and its researchers also million. With space for more than 350 researchers, have a good track record of obtaining private funds. In the CEK receives international scientists and PhD stu- recent years, around €35 million has been obtained at dents, thus fostering the exchange of experience and the institutional level, enabling the acquisition of new professional cooperation. In 2011, it reached its full equipment, the construction of new lab facilities and operating capacity. the modernisation of the old ones. The CEK building houses a large number of the The Esther Koplowitz Research Centre (CEK) is a IDIBAPS teams, covering a massive range of research wonderful example of public and private co-respon- lines. The biomedical progress achieved in the CEK sibility, since it benefits from the participation of the has its grounds in the history and the top-level re- Catalan Autonomous Government (Generalitat de search developed by IDIBAPS over the years. The Catalunya), the Spanish Ministry for the Economy and multitude of international researchers that combine Competitiveness (Ministerio de Economía y Competi- their efforts in the new facilities allows us to look to tividad), the Carlos III Health Institute (Instituto de the future with hope and enthusiasm. 8 INTRODUCTION Management Report 1. Funding of IDIBAPS. IDIBAPS funding in 2011 to- 2. Resource volume generated by the IDIBAPS re- talled more than €21 million. Twenty-seven percent searchers. This is a very significant